Introduction
Protein kinase C (PKC)y, a member of the AGC protein serine/threonine kinases, plays a critical role in T-cell-antigen-receptor (TCR) signaling (Baier, 2003; Tan and Parker, 2003) . Following T-cell stimulation, PKCy translocates to the center of the immunological synapse, where it colocalizes with the TCR. The loss of PKCy function causes immunosuppression, characterized by mostly TCR-unresponsive T cells. Mice lacking PKCy were mainly deficient in the production of interleukin-2 (IL-2) due to impaired NF-kB, AP-1 and NF-AT transactivation (Sun et al, 2000; Pfeifhofer et al, 2003) . The absence of PKCy leads to the induction of T-cell anergy (BergBrown et al, 2004) . Additionally, PKCy was required for the development of a robust immune response controlled by Th2 cells (Marsland et al, 2004) .
Regulation of nearly all AGC-protein kinases requires transphosphorylation of serine/threonine residues in the activation loop and autophosphorylation of the turn and hydrophobic motif (for reviews, see Newton, 2003; Parker and Murray-Rust, 2004) . Conventional PKC isotypes are first phosphorylated in the activation loop by an upstream kinase, PDK-1 or a related enzyme, a step that is essential for its catalytic activity. Then, turn and hydrophobic motif sites are autophosphorylated, and cPKC isotypes adopt a mature and stable conformation ready to be activated by diacylglycerol (DAG) or phorbol ester. For instance, PKCb has activation loop-, turn-and hydrophobic motif sites at Thr-500, Ser-641 and Ser-660, respectively, and these sites are substantially phosphorylated in vivo (Dutil et al, 1998) . Nevertheless, the regulation of the PKC phosphorylation status is still not fully understood and may well differ for the different PKC subfamily members; in T cells, these three classical phosphorylation sites of PKCy (in the activation loop, turn motif and hydrophobic motif) are constitutively phosphorylated and are only slightly induced upon receptor ligation (Liu et al, 2002 , Freeley et al, 2005 and G Baier, unpublished) . However, others have reported that the activation loop is inducibly phosphorylated by PDK1 (Lee et al, 2005) . In addition, PKCy may be tyrosine phosphorylated (Bi et al, 2001 ). In addition, at least one activation-induced autophosphorylation site appears to exist outside the catalytic domain in PKCy (Bauer et al, 2001) , but this site has not been identified nor studied functionally.
We have investigated regulatory autophosphorylation events within the PKCy molecule, which may affect its isotype-selective function in T cells. Here we report a predominant autophosphorylation site, Thr-219, a site within the hinge region of the tandem C1 domains of the regulatory fragment of PKCy. Thr-219 is phosphorylated by isolated recombinant PKCy kinase in vitro and its occupancy occurs at significant stoichiometry in intact cells. In vitro, a neutral exchange mutation of Thr-219, T219A, does not impair second-messenger lipid binding and, in contrast to the established autophosphorylation sites within the catalytic domain of PKCy (Liu et al, 2002) , does not affect the catalytic activity of PKCy. Nevertheless, our data indicate that phosphorylation of Thr-219 regulates targeting and cellular function of PKCy, suggesting that phosphorylation at Thr-219 of PKCy plays a role in its interaction with protein partners and/or effectors. Indeed, Thr-219 phosphorylation of PKCy is required to achieve the established physical and functional crosstalk of PKCy and Akt/PKBa in T cells. Thus, our current findings expand our understanding of the role of antigen receptorinduced autophosphorylation, which contributes to the specific function of PKCy in T cells.
Results

Identification of the predominant activation-induced autophosphorylation site of PKCh as Thr-219
Pilot studies demonstrated that recombinant PKCy undergoes autophosphorylation, as assessed by an in vitro kinase assay performed in the absence of exogenous substrate. As the first step in assessing the major site(s) of phosphorylation of PKCy, samples of in vitro autophosphorylated PKCy were subjected to trypsin digest, HPLC fractionation and radio-sequencing of the fractions ( Figure 1A) . Results demonstrated that the major site of phosphorylation was likely two residues N-terminal to an Arg or Lys, since the signal was exclusively at position 2 in the most highly phosphorylated fraction of tryptic peptides (fraction 14) and substantially at position 2 in the other active fraction (fraction 5). Although there are 12 such Ser/Thr residues in PKCy, our mutational analysis emphasized those Ser/Thr whose surrounding sequence was predicted to be least disfavorable to phosphorylation by PKC (Fujii et al, 2004) , such as Thr-219 and Thr-210. Consistently, mutation of Thr-219 of PKCy resulted in a complete defect of autophosphorylation ( Figure 1B ).
Tryptic peptide maps revealed that phorbol 12,13-dibutyrate (PDBu) stimulation of the recombinant isolated PKCy in vitro caused an increase in 32 P content of several peptides ( Figure 2A ). Several dominant peptides were missing from corresponding maps of the T219A mutant ( Figure 2B ), confirming that Thr-219 was a phosphorylation site. Interestingly, and despite the fact that Thr-219 was the major autophosphorylation site of PKCy, a short peptide thereof (as well as the other trans-and autophosphorylation sites, Thr-538, Ser-676 and Ser-695 in PKCy) was not a suitable peptide substrate in in vitro PKCy kinase assays ( Figure 2C and D) . The PKCy-derived pseudosubstrate peptide, used as positive control, was efficiently phosphorylated.
Confirmation of this novel phosphosite identification was derived from the generation of phospho-specific (p)Thr-219 antisera and site-directed mutagenesis: The specificity of the antiserum for (p)Thr-219 was confirmed by in vitro studies with mutant proteins overexpressed by baculovirus ( Figure 3B ). After addition of PDBu to the isolated proteins in vitro, the phosphopeptide antibody to Thr-219 strongly recognized PKCy. Similarly, phosphopeptide antibody to Thr-538 and Ser-695 reacted in this epitope-specific manner. The antibody was then used to assess PKCy phosphorylation in intact cells. The antiserum reacted strongly with endogenous PKCy in PDBu-stimulated primary mouse CD3 þ cells, but not in unstimulated cells ( Figure 3A ). In intact Jurkat T cells, this Thr-219 phosphorylation site within the regulatory domain of PKCy was also inducibly phosphorylated ( Figure 3C ). We have previously reported an autophosphorylation reaction of PKCy, which was recognized by a broadly reactive phospho-Thr-specific antibody upon activation with PDBu or anti-CD3 crosslinking (Bauer et al, 2001) ; however, the particular residue recognized by the phospho-Thr antibody was not defined. The present study now defines the Thr-219 site as the major site in PKCy. This previously described phospho-Thr-specific antibody bound the T219A mutant much less than wild-type PKCy in Jurkat cells after PDBu stimulation ( Figure 3D ). Consistently, in immunoprecipitation analysis of transiently transfected Jurkat cell lysates, the new (p)Thr-219 antiserum reacted strongly with wild-type PKCy, but not nearly as strong with the corresponding T219A mutant of PKCy ( Figure 3E ). This residual (p)T219 staining of the T219A mutant thereby indicated crossreactivity of our polyclonal antiserum against another yet undefined, but PDBu-inducible, (p)Thr site within PKCy.
Inhibitor studies provided corroboration for the hypothesis that Thr-219 was an autophosphorylation site. In primary CD3
þ T cells, PDBu-inducible phosphorylation on Thr-219 was prevented by preincubating cells with the pan-PKC inhibitor Gö6850, but was not prevented by the cPKC inhibitor Gö6976 ( Figure 4A , upper panel). As a negative specificity control for our phosphopeptide Thr-219-specific antibody, PKCy-deficient CD3 þ T-cell lysates derived from our established PKCy À/À mouse line (Pfeifhofer et al, 2003) did not reveal any band ( Figure 4A , left two lanes). Studies in Jurkat cells confirmed these observations ( Figure 4B ). The fact that phosphorylation was not observed with the ATPbinding defective K409R mutant of PKCy was consistent with our working hypothesis that Thr-219 was an autophosphorylation site. LY-294002, cyclosporine A and rapamycin (relatively specific inhibitors of PI-3 kinase, calcineurin (CaN) and the target of rapamycin kinase (mTOR), respectively) did not inhibit PDBu-induced Thr-219 autophosphorylation (data not shown). Taken together, these results strongly argue that autophosphorylation occurs at this site in PKCy. Next we tested whether antigen receptor activation induced Thr-219 phosphorylation of endogenous PKCy in primary mouse and human T cells. Indeed, CD3/CD28 crosslinking resulted in significant phosphorylation of (p)Thr-219 in mouse CD3 þ cells ( Figure 5A ) and Jurkat cells ( Figure 5B ). Consistent with this finding, phosphorylation was also induced by vanadate, implying a critical upstream role of protein tyrosine phosphorylation. No activation was observed upon okadaic acid (a potent inhibitor of serine/threonine phosphatases) treatment of cells ( Figure 5B ). Furthermore, (p)Thr-219 induction was comparable with CD3 versus CD3 plus CD28 induction. The potential importance of Thr-219 in PKC signaling was further emphasized by the observation that Thr-219 was phosphorylated in primary human CD4 þ cells in response to PDBu, whereas two other known sites of PKCy phosphorylation, Thr-538 and Ser-695, were both found to be constitutively phosphorylated under the experimental conditions used ( Figure 5C ). Thus, combined evidence from phosphopeptide mapping and from a phosphosite-specific antisera identified a novel and activation-inducible autophosphorylation site in PKCy, (p)Thr-219. This site resides within the hinge region of the tandem C1 domains within the regulatory fragment of PKCy.
PKChT219A mutant is intact in its enzymatic activity in vitro
In order to determine whether phosphorylation of PKCy at Thr-219 plays any role in the regulation or function of PKCy, we first studied the T219A mutant in Jurkat cells. PKCy variants were expressed, immunoprecipitated, normalized by their expression levels and analyzed for their kinase activities. As shown in Figure 6A , wild-type PKCy and the PKCyT219A (as well as the acidic exchange mutant PKCyT219E) readily phosphorylated the peptide substrate 
Thr-219 phosphorylation depends on PKCy catalytic activity. PKCy was immunoprecipitated from resting (À) or 20min and 100 nM PDBu-stimulated ( þ ) mouse CD3 þ cells, purified from lymph nodes and spleen (A), and Jurkat cells (B), transfected with GFP control, PKCy wild type or PKCyK406R as indicated. The Thr-219 phosphostatus was determined as in Figure 3 , except that the cells were pretreated for 1 h with distinct PKC inhibitors (at 500 nM concentrations) or DMSO buffer control, as indicated. In contrast, the classical hydrophobic motif autophosphorylation site of PKCy, (p)S695, was constitutively phosphorylated and induced much less upon stimulation (A, lower panel). One representative result out of three independent experiments was shown. in vitro. In contrast, PKCy exhibited reduced activity in mutant constructs lacking phosphorylation sites at Thr-538, Ser-676 and Ser-695. As a negative control, PKCyK409R, an ATP-binding defective and thus kinase-inactive mutant, was used. Reduction in enzymatic activity was especially notable in the activation loop mutant T538A, as defined previously elsewhere (Liu et al, 2002; Xu et al, 2004) .
Baculo-expressed recombinant PKCyT219A mutant also had normal kinase activity, when compared to wild-type PKCy ( Figure 6B ). Since the enzymatic activity was intact and, even slightly enhanced, this excludes the possibility that mutation of Thr-219 had an overall negative effect on the folding or kinase function of PKCy. Therefore, and in contrast to mechanisms proposed for the established autophosphorylation sites within the catalytic domain of PKCy, this novel (p)Thr-219 site does not inhibit catalytic activity in vitro.
Phosphorylation at Thr-219 is required for transactivation of the IL-2 promoter
To test whether phosphorylation at Thr-219 is important for the function of PKCy in TCR-mediated signal transduction, we expressed wild-type and T219A mutant PKCy constructs in Jurkat T cells together with a luciferase reporter gene driven by the entire IL-2 promoter. Here we employed the constitutively active (CA) mutant CA-PKCyA148E (Baier-Bitterlich et al, 1996) , which, in combination with ionomycin, was able to strongly induce transactivation of downstream transcription factors in transfected cells. The CA-PKCyT219A mutant was expressed at levels similar to the wild-type protein, as analyzed by immunoblotting ( Figure 7A, inset) . While cells transfected with the reporter gene alone did not markedly respond to ionomycin stimulation, cells cotransfected with CA-PKCy exhibited an enhanced activation of the IL-2 promoter ( Figure 7A ). In contrast, the CA-PKCyT219A, K409R, T538A and S676A mutants failed to demonstrate enhanced IL-2 promoter activation as compared to the endogenous signaling seen in the GFP inert protein transfection control. Only the CA-PKCyS695A mutant demonstrated slightly enhanced IL-2 transactivation.
These results were confirmed by a modified activation protocol in which transfection with constitutively activated mutant of CaN was used instead of ionomycin stimulation ( Figure 7B ). In accordance with earlier data, the T219A mutant of CA-PKCy (as well as T538A, S676A and S695A) completely failed to mediate NF-AT transactivation in Jurkat T cells under these conditions. Finally, the T219A mutant of CA-PKCy (as well as S676A and S695A) lost its capacity to mediate NF-kB transactivation upon CD3/CD28 crosslinking in Jurkat T-cells ( Figure 7C ). Thus, the T219A mutant was as defective as kinase-dead mutants (K409R and T538A) in activation of transcription via the intact IL-2 promoter or from NF-AT and NF-kB binding elements.
Another useful readout of PKCy function was its phosphorylation of endogenous substrates in transiently transfected Jurkat cells, as measured by immunoblot with an anti-(p)Ser substrate antibody ( Figure 7D) ; expression of the CA-PKCy 
PKChT219A is not enriched at the plasma membrane
In order to investigate the molecular mechanism involved, we determined whether the T219A mutant was able to translocate into the plasma membrane upon cellular activation, employing immunofluorescence staining of transiently transfected Jurkat cells. Once stimulated with superantigen stapphylococcal enterotoxin A (SEA) (presented by Raji B cells), translocation of PKCy protein to the T-and B-cell contact zone was reproducibly observed in the PKCy wildtype, but not in the PKCyT219A mutant, transfected cells ( Figure 8A ). Since the endogenous PKCy protein interferes with studies of transfected PKCy in Jurkat cells, we next confirmed this observation biochemically. Anti-CD3/CD28-stimulated CAPKCy-transfected Jurkat cells were therefore fractionated by sucrose gradient centrifugation to separate the buoyant, detergent-insoluble, glycolipid-enriched lipid rafts from the detergent-soluble fractions of the cells. As reported (Bauer et al, 2003) , the CA mutant of PKCy was found to be strongly enriched in the lipid rafts when expressed and activated in . Luciferase activity in lysates of cells cotransfected with the indicated PKCy expression constructs, luciferase reporter plasmid, and either left unstimulated or stimulated with 500 nM ionomycin or solid-phase CD3/CD28 antibodies for 16 h at 371C. The measured firefly luciferase activity was normalized for transfection efficiency using the renilla luciferase activity, and results were expressed relative to that induced by the unstimulated GFP control. Values represent the average of at least three experiments carried out in duplicates (Po0.005 in (A-C); t-test). (D) Transiently transfected Jurkat T cells were subjected to biochemical fractionation and subsequent immunodetection with a broadly reactive anti-phosphoserine PKC substrate antibody (able to detect distinct phospho-Ser containing endogenous proteins): biochemical fractions corresponding to cytosol (s), membrane (pt) and cytoskeletal fractions (ns) were prepared by standard fractionation, resolved by SDS-PAGE, and the phospho-Ser PKC substrate staining of cellular proteins. Additionally, recombinant expression and relative subcellular distribution of the PKCy mutants (in comparison to the GFP vector control) was determined. As positive evaluation for cell fractionation, immunostaining of p59 fyn predominantly recognized the pt fraction. The results are representative of three experiments. Jurkat T cells ( Figure 8B ). Immunoblot detection of the tightly raft-associated p56 lck provided a positive control for the raft fractionation. However, when the potential raft location of CA-PKCyT219A mutant was analyzed following CD3/CD28 ligation, striking differences were revealed: immunoblots of these fractions demonstrated that, again, this T219A mutant was not induced to redistribute into rafts following CD3/ CD28 stimulation ( Figure 8B ). Differences in cellular location observed were not due to altered expression levels, since the recombinant expression levels of both forms of PKCy in cytosolic fractions of resting cells were nearly identical ( Figure 8C ). These results, which were observed via independent methodology, thus indicate that the T219A mutation impaired the correct targeting of PKCy upon TCR ligation.
Interestingly, the PKCyT538A mutant, which was found to be enzymatically inactivated ( Figure 6A and B above), was still able to autophosphorylate at Thr-219 ( Figure 9A-C) . One potential explanation is that the T538A mutant was not completely kinase-dead but instead had severely reduced catalytic activity. Consistently with the intact Thr-219 autophosphorylation, the T538A mutation did not affect targeting of CA-PKCy to its submembranous location ( Figure 9D ).
One possible explanation for the defect in its submembranous translocation could be that the lipid binding by the regulatory domain was altered by the Thr-219 mutation. However, PDBu binding was not only impaired but even slightly enhanced in the T219A mutant ( Figure 10A ). Analysis of subcellular fractionation revealed that the T219A mutant, similarly to wild-type PKCy, was able to translocate into the plasma membrane upon PDBu stimulation, confirming intact PDBu binding in intact cells ( Figure  10B ). Interestingly, however, in nonstimulated cells, the T219A was enriched in the Triton X-100 nonsoluble (ns) fraction, which again indicated improper subcellular targeting of this PKCy mutant protein.
To directly address the question that default targeting of PKCyT219A to a submembranous location may be responsible for the impaired recruitment and activation of the kinase upon TCR stimulation, we created constitutively plasma membrane-targeted forms of PKCy and its T219A mutant by adding the first 16 amino acids of p56 lck to their NH 2 -termini, as previously carried out for the wild-type enzyme (Bauer et al, 2001 ). This short sequence contains the necessary motifs to drive myristoylation and palmitylation of the proteins. Indeed, these membrane-targeted mutants, wild-type as well as T219A variant of PKCy (MyrPKCy), were found to be constitutively associated with submembranous structures (not shown). As observed in Figure 10C , the membranetargeted PKCyT219A (MyrPKCyT219A) now responded to CD28 and CD3/CD28 stimulation, similarly to MyrPKCy wild type, by increased transactivation of the NF-kB reporter. Thus, MyrPKCyT219A had largely regained the ability to participate in TCR signaling. The impaired activation and function of PKCy caused by replacement of Thr-219 by an Ala can be substantially overcome by forced plasma membrane targeting of the mutant PKCyT219A.
As Akt/PKB and PKCy interact and cooperate during CD3-mediated activation, we also analyzed the location of Akt/PKB. Using biochemical fractionation assays, we found that the impaired recruitment of CA-PKCyT219A mutant also affected endogenous Akt/PKB recruitment into the raft lipid microdomain (Figure 8B above) . Following up on this observation, we investigated whether phosphorylation of Thr-219 was critical for the established crosstalk between PKCy and Akt/PKBa in T cells. While overexpression of both CA-PKCy and Akt/PKBa wild type synergistically increased the activation of NF-kB enhancer ( Figure 11A and; Bauer et al, 2001 ), coexpression of CA-PKCyT219A mutant with Akt/PKBa yielded a level of NF-kB activation similar to that of control vector transfected cells. Similarly, a DPH mutant of Akt/PKBa was incapable of cooperating with CA-PKCy ( Figure 11A ). Moreover, T219A mutation abrogated the physical association of CA-PKCy with endogenous Akt/PKB ( Figure 11B ) assessed by coimmunoprecipitation. Physical association of CA-PKCy with endogenous Akt/PKB in Jurkat cells, however, was not dependent on cellular activation ( Figure 11B ; Bauer et al, 2001 ), but strictly dependent on the presence of the PH domain in Akt/PKBa, since the PHdeletion mutant of Akt/PKBa was incapable of interacting with CA-PKCy ( Figure 11C ).
This indicates that the Thr-219 phosphorylation of PKCy may be an intrinsic structural requirement, indispensable for the physical and functional interaction with Akt/PKB (for a review, see Bauer and Baier, 2002) . Coexpression of the membrane-targeted PKCyT219A (MyrPKCyT219A) mutant with Akt/PKBa again rescued the ability to support signaling via Akt/PKBa to the NF-kB enhancer, similarly to MyrPKCy wild type (not shown). This indicates that proper subcellular targeting of PKCy is a key feature to physically and functionally interact with Akt/PKB. Based on these experiments, we H-PDBu binding as described (Chida and Kuroki, 1983) and (B) stimulated with 100 nM PDBu for 20 min or left unstimulated, as indicated. Subcellular distribution of PKCy (upper panel) and p59 fyn (lower panel) was then determined by immunoblotting. The cell fractions were defined as the soluble (s) fraction, the particulate (pt) fraction and the Triton X-100 nonsoluble (ns) fraction. Note the constitutive enrichment of the T219A mutant in the ns fraction of nonstimulated cells (indicated by the arrow). (C) MyrPKCyT219A synergizes with CD3/CD28 in mediated NF-kB reporter activation. cDNA expression vectors encoding GFP control, wild-type and Myr-NH 2 -terminal fusion mutants of PKCy, respectively, together with the NF-kB reporter plasmid have been cotransfected in Jurkat T cells. After 21 h, cells were stimulated and assayed for reporter gene expression. Expression of the PKCy transgenes has been confirmed by immunoblotting (inset). 
Discussion
The PKCy serine/threonine kinase has been repeatedly implicated in lymphocyte activation, but there has been little precise understanding of the PKCy isotype-selective mechanisms. Mechanism-based understanding of PKCy depends on the characterization of its defined activation steps. Phosphorylation and second-messenger binding, two co-ordinated steps in the PKC activation process, are known to regulate PKC kinases. PKCs share three conserved phosphorylation motifs within their catalytic domain, the activation loop segment, the turn motif and the hydrophobic motif. Phosphorylation at each of these sites regulates the maturation, catalytic competence and thus cellular signaling function, including downregulation of PKC (Newton, 2003; Parker and Murray-Rust, 2004) .
Using phosphopeptide mapping and mutagenesis-based hypothesis testing, we have identified a novel site of regulatory phosphorylation on PKCy, Thr-219, which is located in the hinge region between the C1A and C1B domains, upstream of the catalytic domain of PKCy (see the cartoon in Figure 12 ). Analysis of evolutionary sequence conservation revealed that, within the PKC family members, this sequence surrounding Thr-219 represents a motif, N S R D/E T M/I F, which was found only in the nPKC members of PKCd and y. However, PKCd and y have distinctly different functions in T-cell signaling (Gruber et al, 2005) .
The present analysis showed that Thr-219 was the dominant site of in vitro autophosphorylation. Tryptic peptide maps of recombinant PKCy in vitro confirmed that Thr-219-containing peptides from PKCy contain phosphate (Figures 1  and 2 ). Phosphorylation of Thr-219 is likely to give rise to multiple spots because of the following reasons: (1) the surrounding sequence contains a Met that could also appear in an oxidized state; (2) partial cleavage may occur or (3) there may be additional phosphorylations that depend on prior phosphorylation at Thr-219. It should also be noted that a few additional sites of in vitro autophosphorylation remained to be defined in this phosphopeptide analysis of PKCy, most likely including the established Ser-676 and Ser-695 sites. Nevertheless, Thr-219 was the major in vitro autophosphorylation site of PKCy. The short peptide thereof (and the other autophosphorylation sites, Ser-676 and Ser-695 in PKCy) was not an efficient peptide substrate in in vitro PKCy kinase assays ( Figure 2D ). The pseudosubstrate contains an Arg-and Lys-rich motif, which resembles the PKC consensus sequence. In contrast, the motif of the autophosphorylation sites contained only one Arg or Lys in position À2 or À3. Additionally, the Thr-219 also had a disfavored acidic residue in position À1 (Fujii et al, 2004) . Thus, in cases when the frequency of encounter between kinase and substrate was extremely high, as demonstrated with autophosphorylation sites within the full-length protein kinase, high proximity was most likely dominating over markedly suboptimal substrate consensus sequences (Zhu et al, 2005) . In intact cells, the ATP-binding defective PKCyK409R mutant or, alternatively, the pharmacologically inhibited PKCy was not phosphorylated at Thr-219 upon cellular stimulation (Figure 4) . Thr-219 phosphorylation was inducible both by mitogenic phorbol ester treatment and by CD3 antigen receptor crosslinking ( Figure 5) . Importantly, since experiments were conducted also with endogenous PKCy in primary T cells (Figures 4 and 5) , phosphorylation of Thr-219 appeared to be a physiologically relevant consequence of antigen receptor engagement. Since phosphorylation of Thr-219 required PKC activation, it was reasonable to hypothesize that this activation also resulted in phosphorylation of other physiologically relevant substrates in its vicinity. Consistently, the T219A mutation significantly reduced its ability to phosphorylate endogenous cellular substrates in intact Jurkat T cells ( Figure 7D ). Importantly, however, the in vitro catalytic activity was intact in T219A mutant ( Figure 6 ). Thus, the PKCyT219A mutant was catalytically intact in vitro, but impaired in its cellular function. Indeed, this phosphorylation site proved to be important for the normal function of PKCy, namely for the activation of NF-AT, NF-kB and, subsequently, IL-2 gene activation in the Jurkat cell line ( Figure  7A -C). Our data suggested that phosphorylation at Thr-219 may be involved in properly localizing PKCy within the cell following antigen receptor ligation. Alternatively, changes in the Thr-219 phosphorylation state may simply have altered PKCy protein half-life during its submembranous location. In any case, the T219A PKCy mutant was not found to be properly located in the T-and B-cell contact zone, as well as T-cell submembranous fractions (Figure 8 ), indicating that the change in the phosphorylation state of this residue played a pivotal role in the overall control of localization of this kinase. Interestingly, Thr-219 was found to be autophosphorylated even in the catalytic activity-low mutant T538A (Figures 6 and 9A-C) . Consistently, the T538A mutant did not show any defect in subcellular targeting ( Figure 9D ), indicating that submembranous location of PKCy seemed to be modulated by activation-dependent Thr-219 autophosphorylation, but not solely by PKCy's catalytic competence. The exact mechanisms as well as the protein-binding partner of PKCy, however, remained undefined.
Thus, Thr-219, located in the linker between the tandem C1 domains of the regulatory fragment in PKCy, was an in vitro and in vivo autophosphorylation site in T cells. Autophosphorylation of PKC within the C1 domains had not been identified previously. Another activation-dependent autophosphorylation of related PKC family members on serine and threonine residues outside the catalytic domain had been reported in the C2 domain of PKCe (Pepio and Sossin, 1998) and PKCa (Ng et al, 1999) . In the C1 domain of PKCe, a site close to the Thr-219 in PKCy was established to regulate subcellular location and binding to actin (Prekeris et al, 1996 (Prekeris et al, , 1998 ; however, in PKCe, these cellular functions were regulated by an allosteric switch and not by phosphorylation. Thus, these two regions in PKCy and PKCe are in identical locations within the proteins and are both used for targeting. Therefore, it is plausible that the hinge region between C1A and C1B is an important region for all PKC family members contributing to temporal, spatial and, ultimately, isotype-specific regulation.
Our interpretation of these in vitro data is that PKCy activation is a complex, multi-step process, and it is likely that the tandem C1 domain has multiple, temporally distinct roles. The tandem C1 domain plays an essential role in second-messenger lipid binding early in the activation sequence of PKCy. Phosphorylation of Thr-219 then follows as a second step and this may be a prerequisite for PKCy to interact with its adaptor and scaffold molecules. As one potential mechanism, (p)Thr-219 site could serve to strengthen submembranous association and hinder dissociation of PKCy from a multi-protein complex. Scaffold proteins such as WD40 containing 'RACKs' are candidate-targeting modulators, that is, phosphorylation at Thr-219 may promote binding to another cellular protein at the plasma membrane, which then serves as an anchor in this location. This possibility was supported by our finding that a construct with forced submembranous location mostly restored the ability of the PKCyT219A mutant to mediate CD3/CD28 signaling ( Figure 10C ). Consistent with this concept, our results identified an association between PKCy and Akt/PKB and revealed (p)Thr-219 as an intrinsic structural determinant required for functional crosstalk between PKCy and Akt/PKB in the TCR/ CD28 signal transduction, which involves NF-kB activation (Figure 11 ). This was consistent with the hypothesis that corecruitment of both PKCy and Akt/PKB to the plasma is a critical mechanism leading to activation of the NF-kB pathway (for a review, see Bauer and Baier, 2002) . Indeed, the observed defect in binding of Akt/PKB and PKCyT219A in coimmunoprecipitation experiments ( Figure 11B and C) and in submembranous recruitment of both PKCyT219A and Akt/ PKB ( Figure 8B ) strongly argued in favor of this hypothesis.
We conclude that the primary role of Thr-219 phosphorylation is to target the kinase to the proper membrane microdomain, rather than to regulate its enzymatic activity. Phosphorylation at Thr-219 may promote binding to a multiprotein complex at the plasma membrane, which then serves as an anchor in this location. Consistently, the regulation of signal transduction leading to the activation of the IL-2 promoter depends on (p)Thr-219. Thr-219 phosphorylation thus is an important component of PKCy's isotype-specific function during T-lymphocyte signal transduction.
Materials and methods
Reagents and plasmids
Gö6850, Gö6976, LY333531 and rapamycin were purchased from Alexis, Lausen, Switzerland. g 32 P-ATP was purchased from DuPont NEN, and PDBu and ionomycin from Sigma, both Vienna, Austria. The anti-Akt/PKB antibody was obtained from Cell Signaling Techn., USA. The antibodies used for PKCy were obtained from Santa-Cruz, USA (#sc-1875) and Becton-Dickinson (#1520), respectively. The polyclonal (p)T219 PKCy antibody was raised against (phospho)threonine-containing peptide sequences, NH 2 -I N S R E (p)T 219 M F H K E -COOH, coupled to KLH. Site-directed mutagenesis was performed using the QuikChange kit (Stratagene, La Jolla, CA), following the manufacturer's instructions. Recombinant baculovirus-expressed protein of PKCy wild type and mutants was expressed in Sf21 cells and purified with Ni-NTA-agarose (Quiagen Inc., USA).
